Melbourne Health Breast Cancer Services moves to Phase II/HL7

Melbourne Health Breast Cancer Service Phase II/HL7

The Melbourne Health Breast Cancer Service RUTH II system has moved to Phase II of the implementation with the successful addition of the HL7 module.  The module enables integration to the hospitals’ Patient Administration Systems (PAS).

A key advantage of the extra functionality is the ability to process HL7 A40 merge messages to update each patient’s medical record number to the new Parkville Precinct Unique Record Number (PURN) shared across all three hospitals (including the Peter MacCallum Cancer Centre where the joint weekly Multi-Disciplinary Team Meetings take place).

The integration, coupled with iCIMS’ workflow engine, reduces cognitive load, lowers ‘click fatigue’ and increases accuracy by pre-filling form entries from the PAS and from patient clinical details held within RUTH II. This functionality reduces the time taken by staff to enter data and prepare for Multidisciplinary Team Meetings. Figures from usage data indicate that the RUTH II system has saved over 20% of interns’ data entry time.  Time that is now available to work directly with patients.

Melbourne Health Breast Cancer goes live with RUTH II from iCIMS

Melbourne Health – Breast Cancer Service

Melbourne Health has upgraded its Clinical & Research information management system used by the shared Breast Cancer service of The Royal Melbourne and The Royal Women’s Hospitals. The new system, installed by Innovative Clinical Information Management Systems (iCIMS) is also designed to allow easy access from other institutions within the Parkville precinct.

The iCIMS system (RUTH II) is a full Clinical Information System (CIS) which enables the two hospitals to track the patient journey, manage the Multidisciplinary Team Meetings and transparently share patient information.

iCIMS RUTH II for Royal Melbourne Hospital

iCIMS used its advanced technology to enable a concept it calls Immediate Adaptability to very quickly prototype a system tailored specifically to the needs, workflows and outcomes required by the two hospitals.

One facet of Immediate Adaptability that sets iCIMS developed systems apart is the speed of user-driven system design changes. This speed, in turn, allows iCIMS to deploy a unique installation model; once the initial handover is completed, the client has three months to request system design changes without additional cost.  The result is a highly tailored, fit for purpose solution that has overwhelmingly high user buy-in from senior clinicians, nurses, data administration and ancillary services.

Professor Bruce Mann –   Director of Breast Tumour Stream, Victorian Comprehensive Cancer Centre (VCCC) has seen the effects of iCIMS’ Immediate Adaptability within his team; the MDM team has been very impressed that changes suggested during the MDM one week had been implemented and operational the following week.

As an example of the immediacy of changes, with the RUTH II system, there were 98 design changes requested by the clinical users as a result of them using the system in a live environment in the first three months. Of those changes, 93 have been delivered already with an average turnaround time of 3 days without any system downtime.

As well as the core functionality, the system has additional modules that produce:

  • End of treatment summaries and outcomes
  • A survivorship component
  • Breast audit data exports

RUTH II has been designed to be fully expandable into other tumour streams and other sites within the Parkville precinct and is already remotely accessible from the Peter MacCallum Cancer Centre (PMCC).

iCIMS Welcomes James Dwyer to the Advisory Board

James Dwyer

James Dwyer

iCIMS is pleased to have James Dwyer accept a position on the company’s Advisory Board.

James has been involved in the health and social care industry in Australia and the UK for the last 15 years.

He was formerly the General Manager of EMIS Health in Australia and New Zealand and is also a director of Pineshield Health and Social Care Services in the UK which he founded in 2001.

With a background in financial management in IT and Telecoms since the late 1980’s, James brings strong finance skills as well as personal experience in starting up and growing a successful health and social care organisation.

iCIMS Founder and CEO said that he was very pleased to have James join and believed the experience James has in both Health and Finance would be invaluable as iCIMS moves from start-up mode to a full commercial footing.

iCIMS Announces Formation of Advisory Board

iCIMS and HLA today are excited to announce the formation of a joint Advisory Board, which includes highly experienced executives from the Health and IT sectors, and the Government.

The board members are: Professor David G. Penington AO, John DeBrincat, and Denis Tebbutt. Their brief biographies can be viewed on our website.

Professor Jon Patrick, CEO and founder of iCIMS and HLA said, “To ensure that we continue to focus on developing leading edge health technology solutions, providing exceptional service to our clients, and expanding our footprint into various regions, requires guidance and mentoring by a team of experts who are not involved in the day-to-day business activities.

We are privileged to have David, John and Denis agree to join our advisory board which brings us an unparalleled wealth of experience and vision.”

The iCIMS solutions have been designed to allow clinicians to use highly modifiable and flexible Clinical User Interfaces (CUIs) which increase staff efficiency and patient safety, by implementing detailed but highly adaptable clinical workflows with a strong agile method.

The HLA system provides a unique facility to search, extract and code clinical notes, pathology & radiology reports and other medical texts using a highly efficient natural language processing engine designed for the medical profession.

Announcement: iCIMS-Charm Health Alliance

Charm Health, Australia’s leading provider of specialist oncology eHealth systems, and Innovative Clinical Information Management Systems (iCIMS), developer of a new generation of technology that produces tailored information systems for clinical teams, have announced a strategic alliance to leverage the core strengths of both companies to provide advanced functionality to support the delivery of quality comprehensive oncology services.

Charm Health and iCIMS will collaborate on the creation of transparent interoperability between their systems; CHARM and Patient-Centred Tumour Stream Suite (PTSS). The two organisations will work together to enhance data collection for multi-disciplinary team meetings with a focus on improving the workflows and data collection for individual tumour streams in preparing, conducting and recording outcomes specific to each stream.

Charm Health will also take advantage of iCIMS’s strong capabilities in the design and commissioning of research systems, registries and translational data warehouses. Transparent interoperability between CHARM and PTSS will provide the capability to pass critical data onto research systems and registers connected by iCIMS’ patented native interoperability methodology.

Gary Lakin, CEO of Charm Health, commented, “We are excited by the potential of this alliance to deliver significant benefit to our clients – enhancing the data collection, research and reporting capabilities of our existing solution while providing very customisable solutions to meet the needs of various tumour streams.”

“We are delighted to form this alliance with Charm Health.” said Professor Jon Patrick, CEO of iCIMS. “We look forward to working together to further develop advanced capabilities that enables oncology teams to deliver real value to the patient journey, and add improvements to the delivery of CHARM’s chemotherapy information to the translational researchers working with their medical oncology and surgical colleagues”, commented Patrick.

Download the media release as a PDF.